1. Home
  2. BULL vs LEGN Comparison

BULL vs LEGN Comparison

Compare BULL & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BULL
  • LEGN
  • Stock Information
  • Founded
  • BULL 2016
  • LEGN 2014
  • Country
  • BULL United States
  • LEGN United States
  • Employees
  • BULL N/A
  • LEGN N/A
  • Industry
  • BULL
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BULL
  • LEGN Health Care
  • Exchange
  • BULL NYSE
  • LEGN Nasdaq
  • Market Cap
  • BULL 5.7B
  • LEGN 5.4B
  • IPO Year
  • BULL N/A
  • LEGN 2020
  • Fundamental
  • Price
  • BULL $10.60
  • LEGN $34.00
  • Analyst Decision
  • BULL
  • LEGN Strong Buy
  • Analyst Count
  • BULL 0
  • LEGN 12
  • Target Price
  • BULL N/A
  • LEGN $77.09
  • AVG Volume (30 Days)
  • BULL 9.3M
  • LEGN 2.0M
  • Earning Date
  • BULL 05-22-2025
  • LEGN 08-08-2025
  • Dividend Yield
  • BULL N/A
  • LEGN N/A
  • EPS Growth
  • BULL N/A
  • LEGN N/A
  • EPS
  • BULL 4.12
  • LEGN N/A
  • Revenue
  • BULL $417,404,401.00
  • LEGN $728,303,000.00
  • Revenue This Year
  • BULL N/A
  • LEGN $65.49
  • Revenue Next Year
  • BULL N/A
  • LEGN $53.76
  • P/E Ratio
  • BULL $2.62
  • LEGN N/A
  • Revenue Growth
  • BULL 11.41
  • LEGN 112.46
  • 52 Week Low
  • BULL $9.54
  • LEGN $27.34
  • 52 Week High
  • BULL $79.56
  • LEGN $60.87
  • Technical
  • Relative Strength Index (RSI)
  • BULL N/A
  • LEGN 53.16
  • Support Level
  • BULL N/A
  • LEGN $33.84
  • Resistance Level
  • BULL N/A
  • LEGN $35.29
  • Average True Range (ATR)
  • BULL 0.00
  • LEGN 1.96
  • MACD
  • BULL 0.00
  • LEGN 0.24
  • Stochastic Oscillator
  • BULL 0.00
  • LEGN 52.16

About BULL WEBULL CORPORATION

Webull Corp is a digital investment platform built upon a next-generation global infrastructure. It strives to be the platform of choice for a new generation of investors by creating an efficient, low-cost, and easy-to-use global investment platform. The company distinguishes itself from other investment service providers by offering a mobile-first user experience, a broad range of investment products, and extensive functionality constructed to help its customers build wealth over time. The company arms each customer with the tools it needs to develop into what it refers to as an informed investor - one who understands the market and has the confidence to succeed as an investor. The Webull platform originally provided users with free access to market data and analytical tools.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: